PapersFlow Research Brief
Metastasis and carcinoma case studies
Research Guide
What is Metastasis and carcinoma case studies?
Metastasis and carcinoma case studies are analyses of the metastatic behavior, clinicopathological characteristics, molecular profiling, and therapeutic targets of metastatic carcinomas, particularly from lung tumors and breast cancer, including the role of GATA3 as a prognostic marker and immunohistochemistry in diagnosis.
This field encompasses 30,222 papers on metastatic carcinomas with emphasis on lung tumors and breast cancer. Studies examine GATA3 as a prognostic marker and immunohistochemistry for diagnosis. Research identifies therapeutic targets for these aggressive cancers.
Topic Hierarchy
Research Sub-Topics
GATA3 as Prognostic Marker in Metastatic Carcinoma
This sub-topic evaluates GATA3 immunohistochemical expression as a prognostic indicator in metastatic breast and other carcinomas. Researchers correlate GATA3 status with survival outcomes, metastasis patterns, and therapeutic responses.
Immunohistochemistry in Metastatic Carcinoma Diagnosis
This sub-topic covers IHC panels for identifying primary sites of carcinoma metastases of unknown origin. Researchers validate marker combinations like TTF-1, CDX2, and GATA3 for diagnostic accuracy in clinical pathology.
Molecular Profiling of Metastatic Carcinomas
This sub-topic applies NGS and gene expression profiling to characterize genomic alterations driving carcinoma metastasis. Researchers identify metastasis-specific mutations, fusions, and heterogeneity across primary-metastatic pairs.
Sarcomatoid Carcinoma Clinicopathology
This sub-topic documents histological features, molecular correlates, and aggressive behavior of sarcomatoid dedifferentiation in carcinomas. Researchers analyze prognostic factors and treatment outcomes in lung and pleomorphic variants.
Therapeutic Targets in Metastatic Lung Carcinomas
This sub-topic identifies novel molecular targets and resistance mechanisms in metastatic non-small cell lung carcinomas. Researchers evaluate targeted therapies, immunotherapies, and combinations based on clinicopathological and genomic data.
Why It Matters
Metastasis and carcinoma case studies inform treatments for aggressive cancers by analyzing spread patterns and molecular features. For instance, Yu et al. (2013) showed circulating breast tumor cells undergo dynamic epithelial-mesenchymal transitions, aiding understanding of breast cancer metastasis. Hellman and Weichselbaum (1995) defined oligometastases, guiding targeted therapies for limited metastatic sites. Abrams et al. (1950) analyzed metastases in 1000 autopsied carcinoma cases, revealing common dissemination sites that shape staging and intervention strategies. These insights support perioperative chemotherapy, as Cunningham et al. (2006) demonstrated improved survival in resectable gastroesophageal cancer.
Reading Guide
Where to Start
"THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO‐CALLED INTESTINAL‐TYPE CARCINOMA" by Lauren (1965), as it provides foundational classification of carcinoma histology relevant to metastatic behavior.
Key Papers Explained
Lauren (1965) establishes diffuse and intestinal gastric carcinoma types, which Bokhman (1983) extends to endometrial carcinoma's two pathogenetic types. Abrams et al. (1950) quantifies metastasis patterns across 1000 cases, contextualizing Lauren's histology. Cunningham et al. (2006) tests perioperative chemotherapy on resectable gastroesophageal cancers, building on these classifications for survival outcomes. Yu et al. (2013) adds dynamic cellular changes in breast cancer metastasis.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Field focuses on GATA3 prognostic roles, immunohistochemistry diagnostics, and molecular profiling of lung tumor metastases per cluster description. No recent preprints or news available.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Perioperative Chemotherapy versus Surgery Alone for Resectable... | 2006 | New England Journal of... | 6.2K | ✕ |
| 2 | THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE ... | 1965 | Acta Pathologica Micro... | 6.1K | ✕ |
| 3 | Two pathogenetic types of endometrial carcinoma | 1983 | Gynecologic Oncology | 2.5K | ✕ |
| 4 | Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epit... | 2013 | Science | 2.4K | ✕ |
| 5 | Oligometastases. | 1995 | Journal of Clinical On... | 2.4K | ✕ |
| 6 | <i>PDGFRA</i> Activating Mutations in Gastrointestinal Stromal... | 2003 | Science | 2.3K | ✕ |
| 7 | Pathology and genetics of tumours of the lung , pleura, thymus... | 2004 | — | 2.0K | ✕ |
| 8 | Metastases in carcinoma.Analysis of 1000 autopsied cases | 1950 | Cancer | 1.9K | ✓ |
| 9 | Incidence of lymph node metastasis from early gastric cancer: ... | 2000 | Gastric Cancer | 1.8K | ✓ |
| 10 | Surgical treatment of gastric cancer: 15-year follow-up result... | 2010 | The Lancet Oncology | 1.8K | ✕ |
Frequently Asked Questions
What are the histological types of gastric carcinoma?
Lauren (1965) classified gastric carcinomas into diffuse and intestinal types based on distinct pathogenetic features. The diffuse type shows poor cohesion and infiltrative growth, while the intestinal type forms glandular structures. These distinctions influence prognosis and treatment approaches.
How do circulating tumor cells contribute to breast cancer metastasis?
Yu et al. (2013) found circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition during transit. Epithelial-mesenchymal transition enables migratory states linked to metastasis. This process occurs in human cancer patients.
What is oligometastases in carcinoma?
Hellman and Weichselbaum (1995) defined oligometastases as an intermediate state between localized disease and widespread metastasis. It represents limited metastatic sites amenable to ablative therapies. This concept guides clinical management of carcinoma spread.
What did analysis of 1000 autopsied carcinoma cases reveal about metastases?
Abrams et al. (1950) observed widespread metastases in a high percentage of autopsied carcinoma cases. Common sites included liver, lungs, and bones across various primaries. These patterns highlight the relentless spread of carcinoma.
What are the benefits of perioperative chemotherapy for resectable gastroesophageal cancer?
Cunningham et al. (2006) showed perioperative ECF chemotherapy decreases tumor size and stage compared to surgery alone. It significantly improves progression-free and overall survival in operable gastric or lower esophageal adenocarcinomas. Trial registered as ISRCTN93793971.
What pathogenetic types exist in endometrial carcinoma?
Bokhman (1983) identified two pathogenetic types of endometrial carcinoma. Type I relates to estrogen exposure and hyperplasia, while Type II arises de novo with poor prognosis. These types differ in clinical behavior and molecular features.
Open Research Questions
- ? How do dynamic epithelial-mesenchymal transitions in circulating tumor cells influence metastatic potential in breast carcinoma?
- ? What factors determine progression from oligometastases to polymetastatic disease in lung and gastric carcinomas?
- ? Which molecular profiles best predict lymph node metastasis incidence in early gastric cancer?
- ? How do histological subtypes like diffuse and intestinal gastric carcinoma respond differently to perioperative therapies?
- ? What role do activating mutations play in stromal interactions during gastrointestinal stromal tumor metastasis?
Recent Trends
The cluster includes 30,222 works on metastatic carcinomas from lung tumors and breast cancer, with no specified 5-year growth rate.
Emphasis persists on GATA3 as prognostic marker, immunohistochemistry, and therapeutic targets.
No recent preprints or news reported.
Research Metastasis and carcinoma case studies with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Metastasis and carcinoma case studies with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers